Clinical Trial Update: The DDI Study of SP2086 and Valsartan [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update reporting a drug-drug interaction study between SP2086 and valsartan in individuals with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SP2086
• VALSARTAN (Valsartan)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 1 | Status: UNKNOWN